Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Determinants of diagnostic delay in Chronic Thromboembolic Pulmonary Hypertension: results from the European CTEPH registry.

Klok FA, Barco S, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Delcroix M, Lang IM.

Eur Respir J. 2018 Nov 8. pii: 1801687. doi: 10.1183/13993003.01687-2018. [Epub ahead of print] No abstract available.

PMID:
30409820
2.

Endobronchial ultrasound-guided fine-needle aspiration for pulmonary carcinomas genotyping: experience with 398 cases including rapid EGFR/KRAS analysis in 43 cases.

Ghigna MR, Crutu A, Florea V, Feuillet-Soummer S, Baldeyrou P, Adam J, Lacroix L, Besse B, Mercier O, Fadel E, Dorfmuller P, El Ayoubi R, Thomas de Montpréville V.

J Thorac Dis. 2018 Jul;10(7):4653-4658. doi: 10.21037/jtd.2018.06.157.

3.

Endovascular arch replacement with an endoprosthesis with three inner branches.

Haulon S, Soler R, Watkins AC, Amabile P, Fadel E, Fabre D.

Ann Cardiothorac Surg. 2018 May;7(3):431-433. doi: 10.21037/acs.2018.04.07. No abstract available.

4.

Impact of the initiation of balloon pulmonary angioplasty program on referral of patients with chronic thromboembolic pulmonary hypertension to surgery.

Amsallem M, Guihaire J, Arthur Ataam J, Lamrani L, Boulate D, Mussot S, Fabre D, Taniguchi Y, Haddad F, Sitbon O, Jais X, Humbert M, Simonneau G, Mercier O, Brenot P, Fadel E.

J Heart Lung Transplant. 2018 Sep;37(9):1102-1110. doi: 10.1016/j.healun.2018.05.004. Epub 2018 May 24.

PMID:
30037729
5.

Factors predicting outcome after pulmonary endarterectomy.

Tromeur C, Jaïs X, Mercier O, Couturaud F, Montani D, Savale L, Jevnikar M, Weatherald J, Sitbon O, Parent F, Fabre D, Mussot S, Dartevelle P, Humbert M, Simonneau G, Fadel E.

PLoS One. 2018 Jun 21;13(6):e0198198. doi: 10.1371/journal.pone.0198198. eCollection 2018.

6.

Kissing Stents for Superior Vena Cava Syndrome Due to Mediastinal Fibrosis.

Bardet J, Fabre D, Brenot P, Watkins C, Fadel E.

Open J Cardiovasc Surg. 2018 May 29;10:1179065218771900. doi: 10.1177/1179065218771900. eCollection 2018.

7.

Frozen elephant trunk and arch endografts for chronic thoracoabdominal aortic dissections.

Tinelli G, Ferraresi M, Watkins AC, Soler R, Fadel E, Fabre D, Haulon S.

J Cardiovasc Surg (Torino). 2018 May 22. doi: 10.23736/S0021-9509.18.10579-9. [Epub ahead of print]

PMID:
29786413
8.

Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension.

Taniguchi Y, Brenot P, Jais X, Garcia C, Weatherald J, Planche O, Fadel E, Humbert M, Simonneau G.

Chest. 2018 Sep;154(3):521-531. doi: 10.1016/j.chest.2018.03.059. Epub 2018 May 3.

PMID:
29730328
9.

Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations.

Montani D, Dorfmüller P, Girerd B, Le Pavec J, Fadel E, Simonneau G, Sitbon O, Humbert M.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):537-541. doi: 10.1164/rccm.201802-0317LE. No abstract available.

PMID:
29702008
10.

Analysis of microRNA expression in the thymus of Myasthenia Gravis patients opens new research avenues.

Cron MA, Maillard S, Delisle F, Samson N, Truffault F, Foti M, Fadel E, Guihaire J, Berrih-Aknin S, Le Panse R.

Autoimmun Rev. 2018 Jun;17(6):588-600. doi: 10.1016/j.autrev.2018.01.008. Epub 2018 Apr 13. Review.

PMID:
29655674
11.

Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.

Tamura Y, Phan C, Tu L, Le Hiress M, Thuillet R, Jutant EM, Fadel E, Savale L, Huertas A, Humbert M, Guignabert C.

J Clin Invest. 2018 May 1;128(5):1956-1970. doi: 10.1172/JCI96462. Epub 2018 Apr 9.

12.

Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension.

Guimaron S, Guihaire J, Amsallem M, Haddad F, Fadel E, Mercier O.

Biomed Res Int. 2018 Jan 17;2018:1981568. doi: 10.1155/2018/1981568. eCollection 2018. Review.

13.

[Extracorporeal life support and heart-lung transplant in children].

Hascoet S, Boet A, Nubret K, Lilot M, Feuillet S, Benbrik N, Guihaire J, Le Bret E, Fadel E, Fouilloux V, Amedro P, Houyel L, Kreitmann B.

Presse Med. 2018 Jul - Aug;47(7-8 Pt 1):611-619. doi: 10.1016/j.lpm.2018.01.014. Epub 2018 Mar 24. French.

PMID:
29580908
14.

Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?

Collaud S, Provost B, Besse B, Fabre D, Le Chevalier T, Mercier O, Mussot S, Fadel E.

J Surg Oncol. 2018 Jun;117(7):1570-1574. doi: 10.1002/jso.25042. Epub 2018 Mar 24.

PMID:
29573419
15.

Ewing Sarcoma of the Chest Wall: Prognostic Factors of Multimodal Therapy Including En Bloc Resection.

Provost B, Missenard G, Pricopi C, Mercier O, Mussot S, Fabre D, Langer N, Mir O, Le Pechoux C, Dartevelle P, Fadel E.

Ann Thorac Surg. 2018 Jul;106(1):207-213. doi: 10.1016/j.athoracsur.2018.02.031. Epub 2018 Mar 15.

PMID:
29551629
16.

Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension.

Glorion M, Mercier O, Mitilian D, De Lemos A, Lamrani L, Feuillet S, Pradere P, Le Pavec J, Lehouerou D, Stephan F, Savale L, Fabre D, Mussot S, Fadel E.

Eur J Cardiothorac Surg. 2018 Aug 1;54(2):341-347. doi: 10.1093/ejcts/ezy089.

PMID:
29528384
17.

Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.

Le Hiress M, Akagah B, Bernadat G, Tu L, Thuillet R, Huertas A, Phan C, Fadel E, Simonneau G, Humbert M, Jalce G, Guignabert C.

J Med Chem. 2018 Apr 12;61(7):2725-2736. doi: 10.1021/acs.jmedchem.7b01312. Epub 2018 Mar 19.

PMID:
29526099
18.

Ascending aorta, aortic arch and supra-aortic vessels rupture in blunt thoracic trauma.

Boulate D, Fabre D, Langer NB, Fadel E.

Interact Cardiovasc Thorac Surg. 2018 Aug 1;27(2):304-306. doi: 10.1093/icvts/ivy055.

PMID:
29514278
19.

Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

Loisel F, Provost B, Haddad F, Guihaire J, Amsallem M, Vrtovec B, Fadel E, Uzan G, Mercier O.

Pulm Circ. 2018 Apr-Jun;8(2):2045893218755979. doi: 10.1177/2045893218755979. Epub 2018 Feb 26.

20.

NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.

Dumas SJ, Bru-Mercier G, Courboulin A, Quatredeniers M, Rücker-Martin C, Antigny F, Nakhleh MK, Ranchoux B, Gouadon E, Vinhas MC, Vocelle M, Raymond N, Dorfmüller P, Fadel E, Perros F, Humbert M, Cohen-Kaminsky S.

Circulation. 2018 May 29;137(22):2371-2389. doi: 10.1161/CIRCULATIONAHA.117.029930. Epub 2018 Feb 14.

PMID:
29444988
21.

Tracheal replacement.

Etienne H, Fabre D, Gomez Caro A, Kolb F, Mussot S, Mercier O, Mitilian D, Stephan F, Fadel E, Dartevelle P.

Eur Respir J. 2018 Feb 14;51(2). pii: 1702211. doi: 10.1183/13993003.02211-2017. Print 2018 Feb. Review.

PMID:
29444919
22.

Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension.

Zurlo G, Piquereau J, Moulin M, Pires Da Silva J, Gressette M, Ranchoux B, Garnier A, Ventura-Clapier R, Fadel E, Humbert M, Lemaire C, Perros F, Veksler V.

J Hypertens. 2018 May;36(5):1164-1177. doi: 10.1097/HJH.0000000000001676.

PMID:
29369849
23.

Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.

Lambert M, Boet A, Rucker-Martin C, Mendes-Ferreira P, Capuano V, Hatem S, Adão R, Brás-Silva C, Hautefort A, Michel JB, Dorfmuller P, Fadel E, Kotsimbos T, Price L, Jourdon P, Montani D, Humbert M, Perros F, Antigny F.

Cardiovasc Res. 2018 May 1;114(6):880-893. doi: 10.1093/cvr/cvy016.

PMID:
29360952
24.

Outcome of unexplained acute respiratory distress syndrome with diffuse alveolar damage after lung transplantation.

Stéphan F, de Montpréville VT, Diarra C, Pilorge C, Fadel E, Ghigna MR.

Intensive Care Med. 2018 Apr;44(4):525-527. doi: 10.1007/s00134-018-5050-y. Epub 2018 Jan 20. No abstract available.

PMID:
29353458
25.

Acute decompensated pulmonary hypertension.

Savale L, Weatherald J, Jaïs X, Vuillard C, Boucly A, Jevnikar M, Montani D, Mercier O, Simonneau G, Fadel E, Sitbon O, Humbert M.

Eur Respir Rev. 2017 Nov 15;26(146). pii: 170092. doi: 10.1183/16000617.0092-2017. Print 2017 Dec 31. Review.

26.

Radiotherapy for Tracheal-Bronchial Cystic Adenoid Carcinomas.

Levy A, Omeiri A, Fadel E, Le Péchoux C.

Clin Oncol (R Coll Radiol). 2018 Jan;30(1):39-46. doi: 10.1016/j.clon.2017.10.012. Epub 2017 Nov 6.

PMID:
29122457
27.

[Massive pulmonary embolism. When medical treatment is not enough].

Gerardin B, Glorion M, Rodriguez A, Garcia C, Stephan F, Fabre D, Mercier O, Brenot P, Fadel E.

Ann Cardiol Angeiol (Paris). 2017 Dec;66(6):453-459. doi: 10.1016/j.ancard.2017.10.014. Epub 2017 Nov 7. French.

PMID:
29122207
28.

Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.

Nossent EJ, Antigny F, Montani D, Bogaard HJ, Ghigna MR, Lambert M, Thomas de Montpréville V, Girerd B, Jaïs X, Savale L, Mercier O, Fadel E, Soubrier F, Sitbon O, Simonneau G, Vonk Noordegraaf A, Humbert M, Perros F, Dorfmüller P.

J Heart Lung Transplant. 2018 May;37(5):647-655. doi: 10.1016/j.healun.2017.09.022. Epub 2017 Oct 4.

PMID:
29108819
29.

Prevention of ischemia-reperfusion lung injury during static cold preservation by supplementation of standard preservation solution with HEMO2life® in pig lung transplantation model.

Glorion M, Polard V, Favereau F, Hauet T, Zal F, Fadel E, Sage E.

Artif Cells Nanomed Biotechnol. 2017 Oct 25:1-8. doi: 10.1080/21691401.2017.1392315. [Epub ahead of print]

PMID:
29069926
30.

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension.

Hautefort A, Chesné J, Preussner J, Pullamsetti SS, Tost J, Looso M, Antigny F, Girerd B, Riou M, Eddahibi S, Deleuze JF, Seeger W, Fadel E, Simonneau G, Montani D, Humbert M, Perros F.

Oncotarget. 2017 May 19;8(32):52995-53016. doi: 10.18632/oncotarget.18031. eCollection 2017 Aug 8.

31.

Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined French-Italian Retrospective Multicenter Study.

Marciello F, Mercier O, Ferolla P, Scoazec JY, Filosso PL, Chapelier A, Guggino G, Monaco R, Grimaldi F, Pizzolitto S, Guigay J, de Latour BR, Giuffrida D, Longchampt E, de Montpreville VT, Fadel E, Colao A, Planchard D, Papotti M, Faggiano A, Baudin E.

Neuroendocrinology. 2018;106(3):264-273. doi: 10.1159/000480015. Epub 2017 Aug 17.

PMID:
28813709
32.

Early Development of Right Ventricular Ischemic Lesions in a Novel Large Animal Model of Acute Right Heart Failure in Chronic Thromboembolic Pulmonary Hypertension.

Boulate D, Arthur Ataam J, Connolly AJ, Giraldeau G, Amsallem M, Decante B, Lamrani L, Fadel E, Dorfmuller P, Perros F, Haddad F, Mercier O.

J Card Fail. 2017 Dec;23(12):876-886. doi: 10.1016/j.cardfail.2017.08.447. Epub 2017 Aug 8.

PMID:
28801076
33.

Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration.

Attia M, Maurer M, Robinet M, Le Grand F, Fadel E, Le Panse R, Butler-Browne G, Berrih-Aknin S.

Acta Neuropathol. 2017 Dec;134(6):869-888. doi: 10.1007/s00401-017-1754-2. Epub 2017 Jul 29.

PMID:
28756524
34.

The importance of capillary density-stroke work mismatch for right ventricular adaptation to chronic pressure overload.

Noly PE, Haddad F, Arthur-Ataam J, Langer N, Dorfmüller P, Loisel F, Guihaire J, Decante B, Lamrani L, Fadel E, Mercier O.

J Thorac Cardiovasc Surg. 2017 Dec;154(6):2070-2079. doi: 10.1016/j.jtcvs.2017.05.102. Epub 2017 Jun 15.

PMID:
28712579
35.

Load Adaptability in Patients With Pulmonary Arterial Hypertension.

Amsallem M, Boulate D, Aymami M, Guihaire J, Selej M, Huo J, Denault AY, McConnell MV, Schnittger I, Fadel E, Mercier O, Zamanian RT, Haddad F.

Am J Cardiol. 2017 Sep 1;120(5):874-882. doi: 10.1016/j.amjcard.2017.05.053. Epub 2017 Jun 16.

PMID:
28705377
36.

T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension.

Sankhe S, Manousakidi S, Antigny F, Arthur Ataam J, Bentebbal S, Ruchon Y, Lecerf F, Sabourin J, Price L, Fadel E, Dorfmüller P, Eddahibi S, Humbert M, Perros F, Capuano V.

Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1631-1641. doi: 10.1016/j.bbamcr.2017.06.018. Epub 2017 Jun 24.

37.

Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.

Amsallem M, Sweatt AJ, Aymami MC, Kuznetsova T, Selej M, Lu H, Mercier O, Fadel E, Schnittger I, McConnell MV, Rabinovitch M, Zamanian RT, Haddad F.

Circ Cardiovasc Imaging. 2017 Jun;10(6). pii: e005771. doi: 10.1161/CIRCIMAGING.116.005771.

38.

EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.

Thomas De Montpréville V, Ghigna MR, Lacroix L, Lemoine A, Besse B, Mercier O, Fadel É, Dorfmuller P, Le Chevalier T; Institut d’Oncologie Thoracique.

Pathol Res Pract. 2017 Jul;213(7):793-798. doi: 10.1016/j.prp.2017.03.011. Epub 2017 Mar 30.

PMID:
28554746
39.

Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension.

Savale L, Le Pavec J, Mercier O, Mussot S, Jaïs X, Fabre D, O'Connell C, Montani D, Stephan F, Sitbon O, Simonneau G, Dartevelle P, Humbert M, Fadel E.

Ann Thorac Surg. 2017 Aug;104(2):404-411. doi: 10.1016/j.athoracsur.2017.02.034. Epub 2017 May 18.

PMID:
28527964
40.

Symptomatic Carotid-Bulb Atypical Fibromuscular Dysplasia.

Verscheure D, Fabre D, Smadja D, Fadel E.

Ann Vasc Surg. 2017 Aug;43:310.e1-310.e3. doi: 10.1016/j.avsg.2016.12.023. Epub 2017 May 4.

PMID:
28479449
41.

Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project.

Moser B, Fadel E, Fabre D, Keshavjee S, de Perrot M, Thomas P, Brioude G, Van Raemdonck D, Viskens S, Lang-Lazdunski L, Bille A, Weder W, Jungraithmayr W, Ruffini E, Guerrera F, Gómez de Antonio D, Liberman M, Novoa N, Scarci M, Janik S, Klepetko W.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):346-355. doi: 10.1093/ejcts/ezx090.

42.

Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model.

Sudres M, Maurer M, Robinet M, Bismuth J, Truffault F, Girard D, Dragin N, Attia M, Fadel E, Santelmo N, Sicsic C, Brenner T, Berrih-Aknin S.

JCI Insight. 2017 Apr 6;2(7):e89665. doi: 10.1172/jci.insight.89665.

43.

Extended surgery for T4 lung cancer: a 30 years' experience.

Dartevelle PG, Mitilian D, Fadel E.

Gen Thorac Cardiovasc Surg. 2017 Jun;65(6):321-328. doi: 10.1007/s11748-017-0752-6. Epub 2017 Mar 27. Review.

PMID:
28349384
44.

Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension.

Jenkins D, Madani M, Fadel E, D'Armini AM, Mayer E.

Eur Respir Rev. 2017 Mar 15;26(143). pii: 160111. doi: 10.1183/16000617.0111-2016. Print 2017 Jan. Review.

45.

Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study.

Hascoet S, Fournier E, Jaïs X, Le Gloan L, Dauphin C, Houeijeh A, Godart F, Iriart X, Richard A, Radojevic J, Amedro P, Bosser G, Souletie N, Bernard Y, Moceri P, Bouvaist H, Mauran P, Barre E, Basquin A, Karsenty C, Bonnet D, Iserin L, Sitbon O, Petit J, Fadel E, Humbert M, Ladouceur M.

Arch Cardiovasc Dis. 2017 May;110(5):303-316. doi: 10.1016/j.acvd.2017.01.006. Epub 2017 Mar 9.

46.

Heart transplantation in adults with congenital heart disease.

Houyel L, To-Dumortier NT, Lepers Y, Petit J, Roussin R, Ly M, Lebret E, Fadel E, Hörer J, Hascoët S.

Arch Cardiovasc Dis. 2017 May;110(5):346-353. doi: 10.1016/j.acvd.2017.01.002. Epub 2017 Feb 22. Review.

47.

Evaluation of Reperfusion Pulmonary Edema by Extravascular Lung Water Measurements After Pulmonary Endarterectomy.

Stéphan F, Mazeraud A, Laverdure F, Camous J, Fadel E.

Crit Care Med. 2017 Apr;45(4):e409-e417. doi: 10.1097/CCM.0000000000002259.

PMID:
28145907
48.

Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.

Amsallem M, Boulate D, Kooreman Z, Zamanian RT, Fadel G, Schnittger I, Fadel E, McConnell MV, Dhillon G, Mercier O, Haddad F.

Int J Cardiovasc Imaging. 2017 Jun;33(6):825-835. doi: 10.1007/s10554-017-1069-3. Epub 2017 Jan 24.

PMID:
28120156
49.

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

Montani D, Girerd B, Jaïs X, Levy M, Amar D, Savale L, Dorfmüller P, Seferian A, Lau EM, Eyries M, Le Pavec J, Parent F, Bonnet D, Soubrier F, Fadel E, Sitbon O, Simonneau G, Humbert M.

Lancet Respir Med. 2017 Feb;5(2):125-134. doi: 10.1016/S2213-2600(16)30438-6. Epub 2017 Jan 11.

PMID:
28087362
50.

BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.

Vengethasamy L, Hautefort A, Tielemans B, Belge C, Perros F, Verleden S, Fadel E, Van Raemdonck D, Delcroix M, Quarck R.

Pflugers Arch. 2016 Nov;468(11-12):1969-1983. Epub 2016 Nov 6.

PMID:
27816994

Supplemental Content

Support Center